Ultragenyx Pharmaceutical: Pay

Ultragenyx Pharmaceutical paid its 5 named executives $26.7M in total in FY2025 (Dec). CEO Emil D. Kakkis, M.D., Ph.D. was paid $11.4M of that.

Pay$100 in the stock at the end of FY20 → $17
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Emil D. Kakkis, M.D., Ph.D.President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Erik HarrisChief Commercial Officer and Executive Vice President
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Eric Crombez, M.D.Chief Medical Officer and Executive Vice President
FY2025 (Dec)
FY2024 (Dec)
2 years
Howard HornChief Financial Officer, Corporate Strategy and Executive Vice President
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Karah ParschauerChief Legal Officer and Corporate Affairs, Executive Vice President
FY2025 (Dec)
FY2023 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $14.7M. The CEO of Ultragenyx Pharmaceutical was paid $11.4M, 22% below the median.

  1. 1Exelixis
  2. 2PTC Therapeutics
  3. 3Halozyme Therapeutics
  4. 4BridgeBio Pharma
  5. 5INSMED
  6. 6Ionis Pharmaceuticals
  7. 7Ultragenyx Pharmaceutical
  8. 8Alkermes plc.
  9. 9Neurocrine Biosciences
  10. 10Acadia PharmaceuticalsNot disclosed
  11. 11Amicus TherapeuticsNot disclosed
  12. 12Apellis Pharmaceuticals, Inc.Not disclosed
  13. 13Axsome TherapeuticsNot disclosed
  14. 14Blueprint Medicines CorporationNot disclosed
  15. 15Corcept TherapeuticsNot disclosed
  16. 16Denali Therapeutics Inc.Not disclosed
  17. 17Intra-Cellular Therapies Inc.Not disclosed
  18. 18Jazz PharmaceuticalsNot disclosed
  19. 19Sarepta Therapeutics, Inc.Not disclosed
  20. 20VericelNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.